-
Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al DC CAFC
- 1:08-cv-00330
- D. Del.
- Judge: Sue L. Robinson
- Filed: 06/02/2008
- Closed: 03/24/2011
- Latest Docket Entry: 08/03/2016
- PACER
- Docket updated daily
2
Plaintiffs
3
Defendants
1
Accused
Product
2
Patents-in-Suit
1,026
Days in
Litigation
-
Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al DC CAFC
- 1:08-cv-00330
- D. Del.
- Judge: Sue L. Robinson
- Filed: 06/02/2008
- Closed: 03/24/2011
- Latest Docket Entry: 08/03/2016
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Watson Laboratories, Inc. (Connecticut)
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic fentanyl citrate buccal tablets containing 0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.6 mg, 0.8 mg of fentanyl citrate | US 6,200,604 B1 | All Asserted Claims |
No infringement
Entry 196
|
| Generic fentanyl citrate buccal tablets containing 0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.6 mg, 0.8 mg of fentanyl citrate | US 6,974,590 B2 | All Asserted Claims |
No infringement
Entry 196
|
Watson Pharmaceuticals, Inc.
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic fentanyl citrate buccal tablets containing 0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.6 mg, 0.8 mg of fentanyl citrate | US 6,200,604 B1 | All Asserted Claims |
No infringement
Entry 196
|
| Generic fentanyl citrate buccal tablets containing 0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.6 mg, 0.8 mg of fentanyl citrate | US 6,974,590 B2 | All Asserted Claims |
No infringement
Entry 196
|
